Development of Docetaxel-Loaded Vitamin E TPGS Micelles: Formulation Optimization, Effects on Brain Cancer Cells and Biodistribution in Rats
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
AIM: This work aimed to develop docetaxel-loaded D-α-tocopheryl polyethylene glycol 1000 succinate (vitamin E TPGS or TPGS) micelles for brain cancer chemotherapy by taking advantage of polyethylene glycol for its long half-life in circulation and vitamin E for its high cellular uptake. MATERIAL & METHODS: TPGS micelles containing docetaxel or coumarin-6 were prepared by the solvent casting method and the direct dissolution method at high, moderate and low drug-loading levels. RESULTS & DISCUSSION: The particle size of the docetaxel-loaded TPGS micelles ranged between 12 and 14 nm. Docetaxel formulated in the TPGS micelles of high, moderate and low drug-loading levels achieved lower IC(50) values compared with Taxotere after 24-h incubation with C6 glioma brain cancer cells. The TPGS has much lower critical micelle concentration than most phospholipids in micellar formulation, which can be an efficient drug carrier across the blood brain-barrier with high drug encapsulation efficiency, cell uptake, cytotoxicity and desired biodistribution of the formulated drug.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Thorne, R. G., & Nicholson, C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509425103 · Cited by 641
Stability and release performance of a series of pegylated copolymeric micelles
Lin, W.-J., Juang, L.-W., & Lin, C.-C. (2003) · Pharmaceutical Research · doi:10.1023/a:1023215320026 · Cited by 125
Cited by
Muthu, M. S., Leong, D. T., Mei, L., & Feng, S.-S. (2014) · Theranostics · doi:10.7150/thno.8698 · Cited by 603
Self-citationStrategies to improve micelle stability for drug delivery
Lu, Y., Zhang, E., Yang, J., & Cao, Z. (2018) · Nano Research · doi:10.1007/s12274-018-2152-3 · Cited by 530
Nanoparticles in Drug Delivery: From History to Therapeutic Applications
Afzal, O., Altamimi, A. S. A., Nadeem, M. S., Alzarea, S. I., Almalki, W. H., Tariq, A., Mubeen, B., Murtaza, B. N., Iftikhar, S., Riaz, N., et al. (2022) · Nanomaterials · doi:10.3390/nano12244494 · Cited by 468
Vitamin E-based nanomedicines for anti-cancer drug delivery
Duhem, N., Danhier, F., & Préat, V. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.009 · Cited by 253
Muthu, M. S., Kutty, R. V., Luo, Z., Xie, J., & Feng, S.-S. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2014.11.008 · Cited by 193
“Biodistribution study in normal rats shows that micelles of DTX were found to be present longer time in brain, lungs and blood in comparison to control DTX [19].”
BackgroundMethodInfluentialSelf-citationNanotheranostics: Emerging Strategies for Early Diagnosis and Therapy of Brain Cancer
Sonali, Viswanadh, M. K., Singh, R. P., Agrawal, P., Mehata, A. K., Pawde, D. M., Narendra, Sonkar, R., & Muthu, M. S. (2018) · Nanotheranostics · doi:10.7150/ntno.21638 · Cited by 169
“One of which is receptor-mediated endocytosis which delivers both diagnostic and therapeutic agents simultaneously (Figure 3) [11, 62, 71-74].”
BackgroundInfluentialSelf-citationPawar, A., Patel, R., Arulmozhi, S., & Bothiraja, C. (2016) · RSC Advances · doi:10.1039/c6ra12714b · Cited by 30
Metadata
- Authors
- Muthu, M. S., Avinash Kulkarni, S., Liu, Y., & Feng, S.-S.
- Venue
- Nanomedicine
- Publisher
- Informa UK Limited
- Published
- 2012-03
- Volume
- 7
- Issue
- 3
- Pages
- 353-364
- ISSN
- 1743-5889 (ISSN-L)
- 1748-6963
- OpenAlex
- W2068956748
- Cited by
- 120
- References
- 2
- FWCI
- 2.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.